| Version |
2.5 |
| Creation Date |
2005-11-16 15:48:42 |
| Update Date |
2010-06-07 14:26:13 |
| Accession Number |
HMDB00881 |
| Secondary Accession Numbers |
Not Available |
| Common Name |
Xanthurenic acid |
| Description |
Xanthurenic acid is a metabolite from tryptophan catabolism. It is a substrate of the enzyme methyltransferases [EC 2.1.1.-] in pathway tryptophan metabolism (KEGG). |
| Synonyms |
- 4,8-Dihydroxy-2-quinolinecarboxylate
- 4,8-Dihydroxy-2-quinolinecarboxylic acid
- 4,8-Dihydroxyquinaldate
- 4,8-Dihydroxyquinaldic acid
- 4,8-Dihydroxyquinaldinate
- 4,8-Dihydroxyquinaldinic acid
- 4,8-Dihydroxyquinoline-2-carboxylate
- 4,8-Dihydroxyquinoline-2-carboxylic acid
- 4,8-dihydroxy-Quinaldate
- 4,8-dihydroxy-Quinaldic acid
- 8-Hydroxykynurenate
- 8-Hydroxykynurenic acid
- Xanthurate
- Xanthurenate
- Xanthuric acid;oxoxanthurenate
- 4-oxoxanthurenic acid
|
| Chemical IUPAC Name |
4,8-dihydroxy-quinoline-2-carboxylic acid |
| Chemical Formula |
C10H7NO4 |
| Chemical Structure |
 |
| Chemical Taxonomy |
| Kingdom |
|
| Super Class |
|
| Class |
- Aromatic Acids
- Hydroxy Acids
- Isoquinolines and Quinolines
|
| Sub Class |
|
| Family |
|
| Species |
- phenol or hydroxyhetarene
- carboxylic acid
- aromatic compound
- heterocyclic compound
|
| Biofunction |
| — |
| Application |
| — |
| Source |
|
|
| Average Molecular Weight |
205.167 |
| Monoisotopic Molecular Weight |
205.037506 |
| Isomeric SMILES |
OC(=O)C1=NC2=C(O)C=CC=C2C(O)=C1 |
| Canonical SMILES |
OC(=O)C1=NC2=C(O)C=CC=C2C(O)=C1 |
| KEGG Compound ID |
C02470  |
| BioCyc ID |
XANTHURENATE  |
| BiGG ID |
Not Available |
| Wikipedia Link |
Xanthurenic acid  |
| NuGOwiki Link |
HMDB00881  |
| Metagene Link |
HMDB00881  |
| METLIN ID |
5841  |
| PubChem Compound |
5699  |
| PubChem Substance |
5485  |
| ChEBI ID |
Not Available |
| CAS Registry Number |
59-00-7 |
| InChI Identifier |
InChI=1/C10H7NO4/c12-7-3-1-2-5-8(13)4-6(10(14)15)11-9(5)7/h1-4,12H,(H,11,13)(H,14,15) |
| Synthesis Reference |
Furst, Arthur; Olsen, Carl J. A convenient synthesis of xanthurenic acid. Journal of Organic Chemistry (1951), 16 412-14. |
| Melting Point (Experimental) |
289 oC |
| Experimental Water Solubility |
Not Available
Source: PhysProp
|
| Predicted Water Solubility |
5.89 mg/mL [MEYLAN,WM et al. (1996)]; 1.63 mg/mL [Predicted by ALOGPS]
Calculated using ALOGPS
|
| Physiological Charge |
-1 |
| State |
Solid |
| Experimental LogP/Hydrophobicity |
Not Available
Source: PhysProp
|
| Predicted LogP/Hydrophobicity |
2.01 [Predicted by ALOGPS]; -1.5 [Predicted by PubChem via XLOGP]; 1.06 [MEYLAN,WM & HOWARD,PH (1995)]
Calculated using ALOGPS
|
| Material Safety Data Sheet (MSDS) |
|
| MOL File |
Show |
| SDF File |
Show |
| PDB File |
Show |
| 2D Structure |
|
| 3D Structure |
|
| Experimental PDB ID |
Not Available |
| Experimental 1H NMR Spectrum |
Download Spectrum Download FID (Varian) Show Experimental Conditions  |
| Experimental 13C NMR Spectrum |
Not Available |
| Experimental 13C HSQC Spectrum |
Download Spectrum Download FID (Bruker) Show Experimental Conditions  |
| Predicted 1H NMR Spectrum |
Show Image Show Peaklist
|
| Predicted 13C NMR Spectrum |
Show Image Show Peaklist
|
| Mass Spectrum |
|
| Simplified TOCSY Spectrum |
Not Available |
| BMRB Spectrum |
Not Available |
| Cellular Location |
|
| Biofluid Location |
|
| Tissue Location |
| Tissue |
References |
| Epidermis |
— |
|
| Concentrations (Normal) |
| Biofluid |
Blood |
| Value |
0.022 +/- 0.001 uM |
| Age |
Adult:>18 yrs old |
| Sex |
N/A |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Pawlak D, Pawlak K, Malyszko J, Mysliwiec M, Buczko W: Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol. 2001;33(2):399-404. [PubMed
]
|
| Biofluid |
Urine |
| Value |
2.0 (0.0 - 4.0) umol/mmol creatinine |
| Age |
Children:1-13 yrs old |
| Sex |
N/A |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Christensen M, Duno M, Lund AM, Skovby F, Christensen E: Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase. J Inherit Metab Dis. 2007 Apr;30(2):248-55. Epub 2007 Mar 1. [PubMed
]
|
| Biofluid |
Urine |
| Value |
1.28 +/- 0.44 umol/mmol creatinine |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Geigy Scientific Tables, 8th Rev edition, pp. 165-177. Edited by Cornelius Lentner.
- West Cadwell, N.J. : Medical education Div., Ciba-Geigy Corp.
- Basel, Switzerland c1981-1992.
|
| Biofluid |
Urine |
| Value |
0.10 +/- 0.17 umol/mmol creatinine |
| Age |
Infant:0-1 yr old |
| Sex |
Both |
| Patient information |
Normal |
| Comments |
Not Available |
| References |
- Shoemaker JD, Elliott WH: Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease. J Chromatogr. 1991 Jan 2;562(1-2):125-38. [PubMed
]
|
|
| Concentrations (Abnormal) |
| Biofluid |
Blood |
| Value |
3.0 (2.0 - 4.0) uM |
| Age |
Children:1-13 yrs old |
| Sex |
N/A |
| Condition |
Kynureninase deficiency |
| Comments |
Not Available |
| References |
- Christensen M, Duno M, Lund AM, Skovby F, Christensen E: Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase. J Inherit Metab Dis. 2007 Apr;30(2):248-55. Epub 2007 Mar 1. [PubMed
]
|
| Biofluid |
Blood |
| Value |
0.17 +/- 0.06 uM |
| Age |
Adult:>18 yrs old |
| Sex |
Both |
| Condition |
Hemodialysis |
| Comments |
Not Available |
| References |
- Pawlak D, Pawlak K, Malyszko J, Mysliwiec M, Buczko W: Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol. 2001;33(2):399-404. [PubMed
]
|
| Biofluid |
Urine |
| Value |
200.0 (194.0 - 260.0) umol/mmol creatinine |
| Age |
Children:1-13 yrs old |
| Sex |
N/A |
| Condition |
Kynureninase deficiency |
| Comments |
Not Available |
| References |
- Christensen M, Duno M, Lund AM, Skovby F, Christensen E: Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase. J Inherit Metab Dis. 2007 Apr;30(2):248-55. Epub 2007 Mar 1. [PubMed
]
|
|
| Associated Disorders |
| Condition |
References |
| Hemodialysis |
- Pawlak D, Pawlak K, Malyszko J, Mysliwiec M, Buczko W: Accumulation of toxic products degradation of kynurenine in hemodialyzed patients. Int Urol Nephrol. 2001;33(2):399-404. [PubMed
]
|
| Kynureninase deficiency |
- Christensen M, Duno M, Lund AM, Skovby F, Christensen E: Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase. J Inherit Metab Dis. 2007 Apr;30(2):248-55. Epub 2007 Mar 1. [PubMed
]
|
|
| OMIM ID |
Not Available |
| Pathways |
|
| General References |
- Bapurao S, Krishnaswamy K: Vitamin B6 nutritional status of pellagrins and their leucine tolerance. Am J Clin Nutr. 1978 May;31(5):819-24. [PubMed
]
- Shibata K, Fukuwatari T, Murakami M, Sasaki R: Increase in conversion of tryptophan to niacin in pregnant rats. Adv Exp Med Biol. 2003;527:435-41. [PubMed
]
- Forrest CM, Gould SR, Darlington LG, Stone TW: Levels of purine, kynurenine and lipid peroxidation products in patients with inflammatory bowel disease. Adv Exp Med Biol. 2003;527:395-400. [PubMed
]
- Calandra P: Research on tryptophan metabolites "via kynurenine" in epidermis of man and mouse. Acta Vitaminol Enzymol. 1975;29(1-6):158-60. [PubMed
]
- Hoes MJ, Loeffen T, Vree TB: Kinetics of L-tryptophan in depressive patients: a possible correlation between the plasma concentrations of L-tryptophan and some psychiatric rating scales. Psychopharmacology (Berl). 1981;75(4):350-3. [PubMed
]
- Malina HZ, Hess OM: Xanthurenic acid translocates proapoptotic Bcl-2 family proteins into mitochondria and impairs mitochondrial function. BMC Cell Biol. 2004 Apr 6;5:14. [PubMed
]
- Bapurao S, Raman L, Tulpule PG: Biochemical assessment of vitamin B6 nutritional status in pregnant women with orolingual manifestations. Am J Clin Nutr. 1982 Oct;36(4):581-6. [PubMed
]
- Malina HZ: Comment on 'The photosensitiser xanthurenic acid is not present in normal human lenses' by P.G. Hains et al. [Exp. Eye Res. 77 (2003) 547-553]. Exp Eye Res. 2004 Sep;79(3):443-5; author reply 447-8. [PubMed
]
- Forrest CM, Kennedy A, Stone TW, Stoy N, Darlington LG: Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. Adv Exp Med Biol. 2003;527:287-95. [PubMed
]
- Igari T, Tsuchizawa M, Shimamura T: Alteration of tryptophan metabolism in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis. Tohoku J Exp Med. 1987 Oct;153(2):79-86. [PubMed
]
- Wikipedia

|